Literature DB >> 20537792

Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia.

Siranoush Shahrzad1, Kristen Lacombe, Una Adamcic, Kanwal Minhas, Brenda L Coomber.   

Abstract

We examined the effect of hypoxia on apoptosis of human colorectal cancer (CRC) cells in vitro and in vivo. All cell lines tested were susceptible to hypoxia-induced apoptosis. DCA treatment caused significant apoptosis under normoxia in SW480 and Caco-2 cells, but these cells displayed decreased apoptosis when treated with DCA combined with hypoxia, possibly through HIF-1alpha dependent pathways. DCA treatment also induced significantly increased growth of SW480 tumor xenografts, and a decrease in TUNEL positive nuclei in hypoxic but not normoxic regions of treated tumors. Thus DCA is cytoprotective to some CRC cells under hypoxic conditions, highlighting the need for further investigation before DCA can be used as a reliable apoptosis-inducing agent in cancer therapy. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537792     DOI: 10.1016/j.canlet.2010.04.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

Review 1.  Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

Authors:  Kristofor A Olson; John C Schell; Jared Rutter
Journal:  Trends Biochem Sci       Date:  2016-02-10       Impact factor: 13.807

Review 2.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.

Authors:  Dmitriy Ovcharenko; Catrina Chitjian; Alex Kashkin; Alex Fanelli; Victor Ovcharenko
Journal:  Cancer Biol Ther       Date:  2019-06-24       Impact factor: 4.742

4.  Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo.

Authors:  A Yaromina; S Meyer; C Fabian; K Zaleska; U G A Sattler; L A Kunz-Schughart; W Mueller-Klieser; D Zips; M Baumann
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

5.  A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth.

Authors:  John C Schell; Kristofor A Olson; Lei Jiang; Amy J Hawkins; Jonathan G Van Vranken; Jianxin Xie; Robert A Egnatchik; Espen G Earl; Ralph J DeBerardinis; Jared Rutter
Journal:  Mol Cell       Date:  2014-10-21       Impact factor: 17.970

6.  Effects of supplementing low-protein diets with sodium dichloroacetate and glucose on growth performance, carcass traits, and meat quality of growing-finishing pigs.

Authors:  Yetong Xu; Huiyuan Chen; Ke Wan; Kaifeng Zhou; Yongsheng Wang; Jigang Li; Zhiru Tang; Weizhong Sun; Liuting Wu; Rui An; Zhongxiang Ren; Qi Ding; Kaiyang Liang; Zhihong Sun
Journal:  J Anim Sci       Date:  2022-01-01       Impact factor: 3.159

7.  Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer.

Authors:  Ian F Robey; Natasha K Martin
Journal:  BMC Cancer       Date:  2011-06-10       Impact factor: 4.430

Review 8.  Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Authors:  Wen Zhang; Shao-Lin Zhang; Xiaohui Hu; Kin Yip Tam
Journal:  Int J Biol Sci       Date:  2015-11-01       Impact factor: 6.580

9.  A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.

Authors:  Chrysi Xintaropoulou; Carol Ward; Alan Wise; Hugh Marston; Arran Turnbull; Simon P Langdon
Journal:  Oncotarget       Date:  2015-09-22

10.  Dichloroacetate modulates cytokines toward T helper 1 function via induction of the interleukin-12-interferon-γ pathway.

Authors:  Mujtaba M Badr; Nidal A Qinna; Fadi Qadan; Khalid Z Matalka
Journal:  Onco Targets Ther       Date:  2014-02-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.